Summary
Effects of aspirin (325 and 650 mg) and paracetamol (500 and 1000 mg), and of the centrally acting analgesics meptazinol (100 and 200 mg) and pentazocine (25 and 50 mg) on visuo-motor coordination and dynamic visual acuity, together with critical flicker fusion, digit symbol substitution, complex reaction time and subjective assessments of mood, were studied from 0.75–2.0 h after ingestion by seven healthy female adults. The study was double-blind and placebo controlled, and triprolidine (10 mg) was used as the active control.
No effects of meptazinol and paracetamol on performance were observed. Pentazocine (25 mg) impaired performance on digit symbol substitution (p<0.05) and aspirin (650 mg) appeared to have shortened complex reaction time (p<0.05). Meptazinol (100 mg) increased the component of mood assessments related to wakefulness (p<0.05).
Impaired performance with pentazocine may involve opioid receptor activity, while the apparent alerting effect of meptazinol may relate to its cholinergic activity. The possible effect of aspirin on reaction time needs to be confirmed.
Similar content being viewed by others
References
Anscombe FJ (1961) Examination of residuals. Proc 4th Berkley Symp Math Statist Prob 1: 1–36
Bensreti MM, Golley S, Gonzalez JP, Sewell RDE, Spencer PSJ (1983) Selective and combined antagonism of the biphasic antinociceptive activity of meptazinol using opiate and cholinergic antagonists. Br J Pharmacol 80: 559P
Bill DJ, Hartley JE, Stephens RJ, Thompson AM (1983) The antinociceptive activity of meptazinol depends on both opiate and cholinergic mechanisms. Br J Pharmacol 79: 191–199
Blurton PA, Fox J, Wood MD, Wyllie MG (1982) Interaction of meptazinol with multiple opiate receptors. Br J Pharmacol 77: 508P
Blurton PA, Fox J, Wood MD, Wyllie MG (1982) Meptazinol binds to opiate and non-opiate sites. Br J Pharmacol 77: 507P
Borland RG, Nicholson AN (1974) Human performance after a barbiturate (heptabarbitone). Br J Clin Pharmacol 1: 209–215
Borland RG, Nicholson AN (1984) Visual motor coordination and dynamic visual acuity. Br J Clin Pharmacol 18: 69S-72S
Box GEP, Cox DR (1964) An analysis of transformations. J R Statist Soc B 26: 211–252
Bradley CM, Nicholson AN (1986) Effects of a µ-opioid receptor agonist (codeine phosphate) on visuo-motor coordination and dynamic visual acuity in man. Br J Clin Pharmacol 22: 507–512
Brookhuis K, de Vries G, van Wijngaarden PP, Veenstra G, Hommes M, Louwerens JW, O'Hanlon JF (1985) The effects of increasing doses of meptazinol (100, 200, 400 mg) and glafenine on driving performance. Verkeerskundig Studiecentrum, Rijksuniversiteit Groningen, VK 85-16
Cooper SA (1981) Comparative analgesic efficacies of aspirin and acetaminophen. Arch Intern Med 141: 282–285
Dunn OJ (1961) Multiple comparisons among means. J Am Statist Assoc 56: 52–54
Dunnett CW (1964) New tables for multiple comparisons with a control. Biometrics 20: 482–491
Finney DJ (1946) Standard errors of yields adjusted for regression on an independent measurement. Biometrics 2: 53–55
Franklin RA (1977) The influence of gastric emptying on plasma concentrations of the analgesic, meptazinol. Br J Pharmacol 59: 565–569
Frommel E, Fleury C, Ledebur IV, Beguin M, Family S (1963) The place of acetylsalicylic acid in psychopharmacology. Arzneimittelforsch 13: 851–856
Galli A (1985) Inhibition of cholinesterases by the opioid analgesic meptazinol. Biochem Pharmacol 34: 1579–1581
Green D (1983) Current concepts concerning the mode of action of meptazinol as an analgesic. Postgrad Med J 59 [Suppl 1]: 9–12
Hayes AG, Tyers MB (1983) Determination of receptors that mediate opiate side-effects in the mouse. Br J Pharmacol 79: 731–736
Holingsworth EB, Patrick GA (1984) Sedation produced by prostaglandins is not a nonspecific fatty acid effect. Psychopharmacology 84: 423–425
Kaiser HF (1958) The varimax criterion for analytic rotation in factor analysis. Psychometrika 23: 187–200
Lim RKS, Guzman F, Rodgers DW, Goto K, Braun C, Dickerson GD, Engle RJ (1964) Site of action of narcotic and non-narcotic analgesics determined by blocking bradykininevoked visceral pain. Arch Int Pharmacodyn 152: 25–58
Nicholson AN, Stone BM (1982) Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol 13: 199–202
Nicholson AN, Stone BM (1983) The H1-antagonist mequitazine: Studies on performance and visual function. Eur J Clin Pharmacol 25: 563–566
Nicholson AN, Smith PA, Spencer MB (1982) Antihistamines and visual function: Studies on dynamic acuity and the pupillary response to light. Br J Clin Pharmacol 14: 683–690
Richens A, Jones D, Allen E, Griffiths A, Marshall R (1983) A comparison of intramuscular meptazinol (100 mg) and papaveretum (20 mg) on human performance studies in healthy male volunteers. Postgrad Med J 59 [Suppl 1]: 19–24
Simonson E, Brozek J (1952) Flicker fusion frequency: Background and applications. Physiol Rev 32: 349–378
Stacher G, Steinringer H, Winklehner S, Mittelbach G, Schneider C (1983) Effects of graded oral doses of meptazinol and pentazocine in comparison with placebo on experimentally induced pain in healthy humans. Br J Clin Pharmacol 16: 149–156
Tedeschi G, Smith AT, Richens A (1984) Effect of meptazinol and ethanol on human psychomotor performance and mood ratings. Human Toxicol 3: 37–43
Wade AG, Ward PJ (1982) A double-blind comparison of meptazinol versus paracetamol and placebo in acute and chronic painful conditions presenting to the general practitioner. Curr Med Res Opin 8: 191–196
Ward PJ (1981) Double blind comparison of meptazinol versus pentazocine in patients with chronic backache. Curr Ther Res 30: 507–514
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bradley, C.M., Nicholson, A.N. Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine. Eur J Clin Pharmacol 32, 135–139 (1987). https://doi.org/10.1007/BF00542185
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542185